As previous studies reported, obesity is associated with high levels of insulin, and women with endometrial cancer have an increased endometrial expression of genes involved in the insulin signaling pathway (41, 42). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.